European Markets for Infusion Therapy Devices 2013 – MedSuite

European Markets for Infusion Therapy Devices 2013 – MedSuite


  • Year: 2013
  • Scope: 2009-2019
  • Region: Europe
  • Published Date: 09/01/2013
  • Pages: 202
  • Type: MedSuite

Infusion therapy devices are used for administering fluids or medication directly into a vein. Some disease states are too severe to be treated with oral medications, and must instead be treated intravenously. This is generally facilitated with the use of an intravenous (IV) bag that is connected to a catheter inserted into a vein using plastic IV tubing. Initially, connecting tubing to the catheter inserted into the patient was done by spiking a needle into a connector on the catheter. However, due to concerns over needlestick injuries and the increased incidence of infection when infusing with non-closed systems, European markets have been shifting towards the use of needle-free connectors. Connecting the tubing to the inserted catheter is now done primarily using male luer connections and other connectors that can accept blunt cannulas.

The electronic ambulatory/patient controlled analgesia (PCA) and syringe infusion pump segments are expected to see moderate to high single-digit growth rates until at least 2019.
In 2012, the total European market for infusion therapy devices was valued at over €505 million. This market comprises a mixture of capital equipment and one-time use disposables. These include large volume infusion pumps, syringe infusion pumps, electronic ambulatory/PCA infusion pumps, disposable ambulatory infusion pumps, intravenous (IV) sets and needleless connectors (NLCs). The European infusion therapy device market segments will grow over the forecast period corresponding to two factors: the increasing elderly patient population in Europe and a subsequent increase in diseases that require infusion therapy device treatment. While most segments will experience overall ASP erosion over the forecast period, the syringe infusion and electronic ambulatory/PCA segments’ ASPs will increase slightly as devices become more sophisticated.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.



Sign Up

Already have an account? Sign in